Armata Pharmaceuticals (ARMP) Interest Coverage Ratio (2013 - 2026)
Armata Pharmaceuticals (ARMP) posted Interest Coverage Ratio of 0.15 for Q1 2026, up 94.74% sequentially from 2.86 in Q4 2025, and up 93.38% YoY from 0.08 in Q1 2025.
Armata Pharmaceuticals (ARMP) Interest Coverage Ratio (2013 - 2026) Analysis & Trends
Armata Pharmaceuticals has reported Interest Coverage Ratio for 14 years, with the latest figure at 0.15 in Q1 2026.
- Quarterly Interest Coverage Ratio rose 93.38% year-over-year to 0.15 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.64 (up 75.68% YoY) and the FY2025 annual result came in at 0.37, up 25.64% from the prior year.
- Interest Coverage Ratio rose to 0.15 in Q1 2026 per ARMP's latest filing, from 2.86 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 0.13 in Q3 2025 and troughed at 7112.95 in Q4 2022.
- A 5-year average of 421.37 and a median of 2.27 in 2025 frame the typical range for Interest Coverage Ratio.
- The sharpest annual moves came in 2022 and 2023: Interest Coverage Ratio plunged 251111.25% in 2022, then jumped 99.91% in 2023.
- Over 5 years, Interest Coverage Ratio stood at 7112.95 in 2022, then jumped by 99.91% to 6.61 in 2023, then surged by 77.22% to 1.5 in 2024, then tumbled by 90.04% to 2.86 in 2025, then soared by 94.74% to 0.15 in 2026.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 0.15, 2.86, and 0.13 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | Armata Pharmaceuticals | 182.82 Mn | 158.82 Mn | - | -1.55 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.18 |
| Mar 31, 2026 | -0.15 |
| Dec 31, 2025 | -2.86 |
| Sep 30, 2025 | -0.13 |
| Jun 30, 2025 | -1.22 |
| Mar 31, 2025 | -2.27 |
| Dec 31, 2024 | -1.50 |
| Sep 30, 2024 | -0.15 |
| Jun 30, 2024 | -0.17 |
| Mar 31, 2024 | -3.05 |
| Dec 31, 2023 | -6.61 |
| Sep 30, 2023 | -8.79 |
| Jun 30, 2023 | -1.78 |
| Mar 31, 2023 | -2.18 |
| Dec 31, 2022 | -7,112.95 |
| Sep 30, 2022 | -6.17 |
| Jun 30, 2022 | -9.96 |
| Mar 31, 2022 | -3.38 |
| Dec 31, 2021 | -2.83 |
| Sep 30, 2021 | -10.09 |